STOCK TITAN

Surrozen Inc Financials

SRZNW
Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

This page shows Surrozen Inc (SRZNW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 36 / 100
Financial Profile 36/100

Based on FY2024 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Surrozen Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
0

Surrozen Inc has an operating margin of -239.7%, meaning the company retains $-240 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses.

Leverage
98

Surrozen Inc carries a low D/E ratio of -3.27, meaning only $-3.27 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 98/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
100

With a current ratio of 5.32, Surrozen Inc holds $5.32 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Cash Flow
0

While Surrozen Inc generated -$17.6M in operating cash flow, capex of $26K consumed most of it, leaving -$17.7M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Piotroski F-Score Weak
2/9

Surrozen Inc passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Low Quality
0.28x

For every $1 of reported earnings, Surrozen Inc generates $0.28 in operating cash flow (-$17.6M OCF vs -$63.6M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$10.7M

Surrozen Inc generated $10.7M in revenue in fiscal year 2024.

EBITDA
-$24.1M
YoY+45.1%

Surrozen Inc's EBITDA was -$24.1M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 45.1% from the prior year.

Net Income
-$63.6M
YoY-47.7%

Surrozen Inc reported -$63.6M in net income in fiscal year 2024. This represents a decrease of 47.7% from the prior year.

EPS (Diluted)
$-21.67
YoY-1.6%

Surrozen Inc earned $-21.67 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 1.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$17.7M
YoY+56.7%

Surrozen Inc generated -$17.7M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 56.7% from the prior year.

Cash & Debt
$34.6M
YoY-4.1%

Surrozen Inc held $34.6M in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share
N/A
Shares Outstanding
3M
YoY+58.1%

Surrozen Inc had 3M shares outstanding in fiscal year 2024. This represents an increase of 58.1% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
-239.7%

Surrozen Inc's operating margin was -239.7% in fiscal year 2024, reflecting core business profitability.

Net Margin
-596.6%

Surrozen Inc's net profit margin was -596.6% in fiscal year 2024, showing the share of revenue converted to profit.

Return on Equity
N/A

Capital Allocation

R&D Spending
$21.1M
YoY-22.4%

Surrozen Inc invested $21.1M in research and development in fiscal year 2024. This represents a decrease of 22.4% from the prior year.

Share Buybacks
N/A
Capital Expenditures
$26K
YoY-93.5%

Surrozen Inc invested $26K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 93.5% from the prior year.

SRZNW Income Statement

Metric Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23
Revenue $983K0.0% $983K0.0% $983K N/A $10.0M $0 $0 N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses $7.8M+28.7% $6.0M-7.9% $6.6M N/A $5.2M-2.5% $5.3M+1.7% $5.2M N/A
SG&A Expenses $4.1M+3.4% $4.0M-0.5% $4.0M N/A $3.6M-3.9% $3.7M-4.4% $3.9M N/A
Operating Income -$10.9M-20.7% -$9.0M+5.6% -$9.6M N/A $1.2M+113.6% -$9.0M+0.9% -$9.1M N/A
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income -$71.6M-280.3% $39.7M+247.4% -$27.0M N/A -$1.4M+94.3% -$25.3M-186.1% -$8.8M N/A
EPS (Diluted) $-8.36-427.8% $2.55+134.3% $-7.43 N/A $-0.44+94.5% $-7.99-88.4% $-4.24 N/A

SRZNW Balance Sheet

Metric Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23
Total Assets $94.0M-8.4% $102.7M-10.6% $114.8M+136.9% $48.5M+1.0% $48.0M+6.5% $45.1M+22.8% $36.7M-20.3% $46.1M
Current Assets $85.9M-8.9% $94.2M-11.1% $106.0M+172.3% $38.9M-14.0% $45.3M+8.8% $41.6M+30.1% $32.0M-22.2% $41.1M
Cash & Equivalents $81.3M-10.0% $90.4M-11.1% $101.6M+194.1% $34.6M+11.5% $31.0M-17.9% $37.8M+38.4% $27.3M-24.3% $36.0M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable $2.3M0.0% $2.3M+8.8% $2.1M+4.5% $2.0M-83.3% $12.2M+477.5% $2.1M-0.8% $2.1M-1.1% $2.2M
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $117.6M+111.5% $55.6M-49.1% $109.2M+56.3% $69.8M+65.0% $42.3M+8.5% $39.0M+492.8% $6.6M-19.2% $8.1M
Current Liabilities $6.5M+13.7% $5.7M-45.7% $10.6M+44.7% $7.3M+19.5% $6.1M+2.3% $6.0M-3.2% $6.2M-13.6% $7.1M
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity -$23.5M-149.9% $47.1M+730.3% $5.7M+126.5% -$21.4M-477.3% $5.7M-6.5% $6.1M-79.9% $30.1M-20.6% $37.9M
Retained Earnings -$344.1M-26.3% -$272.5M+12.7% -$312.2M-9.5% -$285.3M-10.9% -$257.2M-0.6% -$255.8M-11.0% -$230.5M-4.0% -$221.7M

SRZNW Cash Flow Statement

Metric Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23
Operating Cash Flow -$9.0M-47.9% -$6.1M+34.1% -$9.3M-366.6% $3.5M+151.6% -$6.8M-20.3% -$5.6M+35.8% -$8.7M-19.6% -$7.3M
Capital Expenditures $24K+33.3% $18K-33.3% $27K+42.1% $19K $0 $0-100.0% $7K $0
Free Cash Flow -$9.1M-47.8% -$6.1M+34.1% -$9.3M-368.8% $3.5M+151.3% -$6.8M-20.3% -$5.6M+35.9% -$8.8M-19.7% -$7.3M
Investing Cash Flow -$24K-33.3% -$18K+33.3% -$27K-42.1% -$19K $0 $0+100.0% -$7K-100.1% $9.5M
Financing Cash Flow $9K+100.2% -$5.1M-106.7% $76.4M+83840.7% $91K+9200.0% -$1K-100.0% $16.1M $0-100.0% $141K
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

SRZNW Financial Ratios

Metric Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin -1107.3%-190.0pp -917.3%+54.3pp -971.6% N/A 12.3% N/A N/A N/A
Net Margin -7288.2%-11331.5pp 4043.3%+6787.0pp -2743.6% N/A -14.3% N/A N/A N/A
Return on Equity N/A 84.4%+559.7pp -475.3% N/A -25.3%+391.4pp -416.7%-387.4pp -29.3% N/A
Return on Assets -76.2%-114.9pp 38.7%+62.2pp -23.5% N/A -3.0%+53.1pp -56.0%-32.0pp -24.1% N/A
Current Ratio 13.15-3.3 16.41+6.4 10.02+4.7 5.32-2.1 7.40+0.4 6.96+1.8 5.18-0.6 5.75
Debt-to-Equity -5.00-6.2 1.18-18.1 19.24+22.5 -3.27-10.7 7.47+1.0 6.43+6.2 0.220.0 0.21
FCF Margin -922.1%-298.4pp -623.7%+323.0pp -946.7% N/A -67.5% N/A N/A N/A

Note: Shareholder equity is negative (-$21.4M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Frequently Asked Questions

Surrozen Inc (SRZNW) reported $10.7M in total revenue for fiscal year 2024. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

No, Surrozen Inc (SRZNW) reported a net income of -$63.6M in fiscal year 2024, with a net profit margin of -596.6%.

Surrozen Inc (SRZNW) reported diluted earnings per share of $-21.67 for fiscal year 2024. This represents a -1.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Surrozen Inc (SRZNW) had EBITDA of -$24.1M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

Surrozen Inc (SRZNW) had an operating margin of -239.7% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

Surrozen Inc (SRZNW) had a net profit margin of -596.6% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

Surrozen Inc (SRZNW) generated -$17.7M in free cash flow during fiscal year 2024. This represents a 56.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Surrozen Inc (SRZNW) generated -$17.6M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

Surrozen Inc (SRZNW) had $48.5M in total assets as of fiscal year 2024, including both current and long-term assets.

Surrozen Inc (SRZNW) invested $26K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

Surrozen Inc (SRZNW) invested $21.1M in research and development during fiscal year 2024.

Surrozen Inc (SRZNW) had 3M shares outstanding as of fiscal year 2024.

Surrozen Inc (SRZNW) had a current ratio of 5.32 as of fiscal year 2024, which is generally considered healthy.

Surrozen Inc (SRZNW) had a debt-to-equity ratio of -3.27 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

Surrozen Inc (SRZNW) had a return on assets of -131.2% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2024 data, Surrozen Inc (SRZNW) had $34.6M in cash against an annual operating cash burn of $17.6M. This gives an estimated cash runway of approximately 24 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Surrozen Inc (SRZNW) has negative shareholder equity of -$21.4M as of fiscal year 2024, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Surrozen Inc (SRZNW) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Surrozen Inc (SRZNW) has an earnings quality ratio of 0.28x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Surrozen Inc (SRZNW) scores 36 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top